Our findings reported herein provide additional support for the idea that BMAL1 is an important partner in HIF2α-driven gene regulation and show that this is relevant to ccRCC, in which HIF2α is a key driver. This evidence concerns the gene BMAL1 and nonpapillary renal cell carcinoma.